Allogeneic Stem Cell Transplant for Acute Myeloid Leukemia


The hematologist from UC Health discussed the role of allogeneic stem cell transplant at first remission based on risk stratification.

This content originally appeared on our sister site, OncLive.

Related Videos
Carlos Moraes, PhD, on Understanding Mitochondrial Mutations for Neurodegenerative Diseases
Aude Chapuis, MD, an associate professor in the Translational Science and Therapeutics Division at Fred Hutch Cancer Center
Amar Kelkar, MD, a stem cell transplantation physician at the Dana-Farber Cancer Institute
Frederick “Eric” Arnold, PhD
David Porter, MD
Raj Chovatiya, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.